Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://www.insideprecisionmedicine.com/topics/oncology/lung-cancer/md-anderson-researchers-id-cd70-as-new-target-in-egfr-mutant-nsclc/
0
0
MD Anderson Researchers ID CD70 as New Target in EGFR-Mutant NSCLC - Inside Precision Medicine
2/15/23 at 7:54pm
Organization
Insideprecisionmedicine.com
Author
Chris Anderson
35 words
0
Comments
CD70 is highly expressed in EGFR-mutant non-small cell lung cancer (NSCLC) representing a promising new target for treatment.
Health
Business & Industrial
News
Precision Medicine CD70
ID CD70
MD Anderson Researchers
EGFR
Target
Gene Mutations
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...